Rchr
J-GLOBAL ID:200901076938836781   Update date: Jul. 16, 2024

Hirayama Noriaki

Hirayama Noriaki
Research field  (1): Pharmaceuticals - chemistry and drug development
Research keywords  (2): 創薬 ,  drug discovery
Research theme for competitive and other funds  (19):
  • 2020 - 2024 The investigation of the new small molecule inhibitors of IL-17A for intervertebral disc disease treatment by In Silico analysis
  • 2019 - 2021 Analysis of cancer antigens through novel HLA assay
  • 2016 - 2020 Intervertebral disc regeneration and transcriptional control of nucleus pulpous progenitor cells by in silico pharmacogenesis and iPS technology
  • 2016 - 2018 The exploration of new drug for the treatment of Notch-active tumor cells.
  • 2015 - 2018 Development of cultured skin which has tolerance in ischemia.
Show all
Papers (22):
more...
Professional career (1):
  • Dr of Science (Tokyo Institute of Technology)
Association Membership(s) (4):
THE PHARMACEUTICAL SOCIETY OF JAPAN ,  CBI学会 ,  Chem-Bio Information Society ,  American Chemical Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page